{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:48:37Z","timestamp":1791557317630,"version":"4.3.4"},"reference-count":254,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC), the predominant form of primary liver\nmalignancy, remains a major global health concern owing to its aggressive progression, limited\ntherapeutic efficacy, and high fatality rate. A significant proportion of HCC arises from chronic exposure\nto chemical carcinogens, which trigger hepatocarcinogenesis through oxidative stress, DNA\ndamage, and dysregulation of signalling networks. Natural compounds, particularly beta-carboline\nalkaloids, are emerging as safer, multi-targeted candidates with promising hepatoprotective and anticancer\npotential. This review has critically evaluated chemical-induced hepatocarcinogenesis and\nthe therapeutic relevance of beta-carbolines in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic literature survey was conducted using PubMed, Scopus, and Web of Science\ndatabases, emphasizing studies on chemical-induced HCC, natural hepatoprotective compounds,\nand beta-carboline derivatives. Mechanistic, pharmacological, and preclinical data were extracted\nand analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Carcinogens, such as diethylnitrosamine (DEN), aflatoxin B1, and carbon tetrachloride\n(CCl4), promote HCC by inducing oxidative stress, genotoxicity, and perturbations in signalling\ncascades, including PI3K\/AKT, Wnt\/\u03b2-catenin, and NF-\u03baB. Beta-carbolines display antioxidant,\npro-apoptotic, anti-inflammatory, and anti-metastatic activities, with evidence of direct modulation\nof oncogenic pathways and tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The accumulating evidence highlights beta-carbolines as versatile natural agents with\nmulti-faceted mechanisms against chemical-induced hepatocarcinogenesis. Nonetheless, gaps remain\nin understanding their pharmacokinetics, bioavailability, and long-term safety. Preclinical data\nare encouraging, but translational studies and clinical validations are limited, underscoring the need\nfor further research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Beta-carboline alkaloids hold significant promise as therapeutic candidates for chemical-\ninduced HCC. Addressing challenges related to safety, bioavailability, and clinical applicability\ncan prove to be crucial for their future development<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575415295250922074231","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:58:53Z","timestamp":1760353133000},"page":"201-236","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting Chemical-induced Hepatocellular Carcinoma: Ameliorative Potential of Natural Compounds with Focus on Beta-carbolines"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9985-3481","authenticated-orcid":true,"given":"Aloke","family":"Saha","sequence":"first","affiliation":[{"name":"Department of Zoology, University of Kalyani, Kalyani 741235, Nadia, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9918-2990","authenticated-orcid":true,"given":"Paromita","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Kalyani, Kalyani 741235, Nadia, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debjani","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Kalyani, Kalyani 741235, Nadia, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakali","family":"Bhadra","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Kalyani, Kalyani 741235, Nadia, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"Yang J.D.","year":"2019","unstructured":"Yang J.D.; Hainaut P.; Gores G.J.; Amadou A.; Plymoth A.; Roberts L.R.; A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol  2019,16(10),589-604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/S1462399411002110","volume":"14","author":"Gu X.","year":"2012","unstructured":"Gu X.; Manautou J.E.; Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med  2012,14,e4","journal-title":"Expert Rev Mol Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F.","year":"2024","unstructured":"Bray F.; Laversanne M.; Sung H.; Ferlay J.; Siegel R.L.; Soerjomataram I.; Jemal A.; Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2024,74(3),229-263","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"Singal A.G.","year":"2020","unstructured":"Singal A.G.; Lampertico P.; Nahon P.; Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol  2020,72(2),250-261","journal-title":"J Hepatol"},{"key":"ref=5","year":"2025","unstructured":"Cancer impact: New cervical cancer elimination planning tool now available.  Available from:  https:\/\/gco.iarc.fr\/2025"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ije\/dyaa196","volume":"50","author":"Liu Z.","year":"2021","unstructured":"Liu Z.; Xu K.; Jiang Y.; Cai N.; Fan J.; Mao X.; Suo C.; Jin L.; Zhang T.; Chen X.; Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: A modelling study. Int J Epidemiol  2021,50(1),128-142","journal-title":"Int J Epidemiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmi.2015.06.026","volume":"21","author":"Schinzari V.","year":"2015","unstructured":"Schinzari V.; Barnaba V.; Piconese S.; Chronic hepatitis B virus and hepatitis C virus infections and cancer: Synergy between viral and host factors. Clin Microbiol Infect  2015,21(11),969-974","journal-title":"Clin Microbiol Infect"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/HMER.S278070","volume":"12","author":"Barsouk A.","year":"2021","unstructured":"Barsouk A.; Thandra K.C.; Saginala K.; Rawla P.; Barsouk A.; Chemical risk factors of primary liver cancer: An update. Hepat Med  2021,12,179-188","journal-title":"Hepat Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2006.12.010","volume":"252","author":"Wu H.C.","year":"2007","unstructured":"Wu H.C.; Wang Q.; Wang L.W.; Yang H.I.; Ahsan H.; Tsai W.Y.; Wang L.Y.; Chen S.Y.; Chen C.J.; Santella R.M.; Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Lett  2007,252(1),104-114","journal-title":"Cancer Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/ol.2013.1169","volume":"5","author":"Hamid A.S.","year":"2013","unstructured":"Hamid A.S.; Tesfamariam I.G.; Zhang Y.; Zhang Z.G.; Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncol Lett  2013,5(4),1087-1092","journal-title":"Oncol Lett"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.3390\/ijms21155461","volume":"21","author":"Memon A.","year":"2020","unstructured":"Memon A.; Pyao Y.; Jung Y.; Lee J.I.; Lee W.K.; A modified protocol of diethylnitrosamine administration in mice to model hepatocellular carcinoma. Int J Mol Sci  2020,21(15),5461","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/gut.51.1.132","volume":"51","author":"Stickel F.","year":"2002","unstructured":"Stickel F.; Schuppan D.; Hahn E.G.; Seitz H.K.; Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut  2002,51(1),132-139","journal-title":"Gut"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4251\/wjgo.v13.i5.424","volume":"13","author":"Elshaarawy O.","year":"2021","unstructured":"Elshaarawy O.; Aman A.; Zakaria H.M.; Zakareya T.; Gomaa A.; Elshimi E.; Abdelsameea E.; Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis. World J Gastrointest Oncol  2021,13(5),424-439","journal-title":"World J Gastrointest Oncol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/00000658-200204000-00004","volume":"235","author":"Poon R.T.P.","year":"2002","unstructured":"Poon R.T.P.; Fan S.T.; Tsang F.H.F.; Wong J.; Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon\u2019s perspective. Ann Surg  2002,235(4),466-486","journal-title":"Ann Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e430028","DOI":"10.1200\/EDBK_430028","volume":"44","author":"Ntellas P.","year":"2024","unstructured":"Ntellas P.; Chau I.; Updates on systemic therapy for hepatocellular carcinoma. Am Soc Clin Oncol Educ Book  2024,44(1),e430028","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"Shen K.Y.","year":"2024","unstructured":"Shen K.Y.; Zhu Y.; Xie S.Z.; Qin L.X.; Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: Current status and prospectives. J Hematol Oncol  2024,17(1),25","journal-title":"J Hematol Oncol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"9068850","DOI":"10.1155\/2021\/9068850","volume":"2021","author":"Jain D.","year":"2021","unstructured":"Jain D.; Murti Y.; Khan W.U.; Hossain R.; Hossain M.N.; Agrawal K.K.; Ashraf R.A.; Islam M.T.; Janmeda P.; Taheri Y.; Alshehri M.M.; Da\u015ftan S.D.; Yeskaliyeva B.; Kipchakbayeva A.; Sharifi-Rad J.; Cho W.C.; Roles of therapeutic bioactive compounds in hepatocellular carcinoma. Oxid Med Cell Longev  2021,2021(1),9068850","journal-title":"Oxid Med Cell Longev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/antiox10091455","volume":"10","author":"George B.P.","year":"2021","unstructured":"George B.P.; Chandran R.; Abrahamse H.; Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants  2021,10(9),1455","journal-title":"Antioxidants"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"Naeem A.","year":"2022","unstructured":"Naeem A.; Hu P.; Yang M.; Zhang J.; Liu Y.; Zhu W.; Zheng Q.; Natural products as anticancer agents: Current status and future perspectives. Molecules  2022,27(23),8367","journal-title":"Molecules"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"947226","DOI":"10.3389\/fmicb.2022.947226","volume":"13","author":"Hao M.J.","year":"2022","unstructured":"Hao M.J.; Chen P.N.; Li H.J.; Wu F.; Zhang G.Y.; Shao Z.Z.; Liu X.P.; Ma W.Z.; Xu J.; Mahmud T.; Lan W.J.; \u03b2-carboline alkaloids from the deep-sea fungus Trichoderma sp. MCCC 3A01244 as a new type of anti-pulmonary fibrosis agent that inhibits TGF-\u03b2\/Smad signaling pathway. Front Microbiol  2022,13,947226","journal-title":"Front Microbiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"173837","DOI":"10.1016\/j.ejphar.2020.173837","volume":"893","author":"Ayipo Y.O.","year":"2021","unstructured":"Ayipo Y.O.; Mordi M.N.; Mustapha M.; Damodaran T.; Neuropharmacological potentials of \u03b2-carboline alkaloids for neuropsychiatric disorders. Eur J Pharmacol  2021,893,173837","journal-title":"Eur J Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/1871520614666141128121812","volume":"15","author":"Zhang M.","year":"2015","unstructured":"Zhang M.; Sun D.; Recent advances of natural and synthetic \u03b2-carbolines as anticancer agents. Anticancer Agents Med Chem  2015,15(5),537-547","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jphotobiol.2010.05.005","volume":"100","author":"Nafisi S.","year":"2010","unstructured":"Nafisi S.; Bonsaii M.; Maali P.; Khalilzadeh M.A.; Manouchehri F.; \u03b2-Carboline alkaloids bind DNA. J Photochem Photobiol B  2010,100(2),84-91","journal-title":"J Photochem Photobiol B"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e2687","DOI":"10.1002\/jmr.2687","volume":"31","author":"Bhattacharjee P.","year":"2018","unstructured":"Bhattacharjee P.; Ghosh T.; Sarkar S.; Pandya P.; Bhadra K.; Binding affinity and in vitro cytotoxicity of harmaline targeting different motifs of nucleic acids: An ultimate drug designing approach. J Mol Recognit  2018,31(4),e2687","journal-title":"J Mol Recognit"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.2174\/1389557518666171211164830","volume":"18","author":"Sarkar S.","year":"2018","unstructured":"Sarkar S.; Bhadra K.; Therapeutic role of harmalol targeting nucleic acids: Biophysical perspective and in vitro cytotoxicity. Mini Rev Med Chem  2018,18(19),1624-1639","journal-title":"Mini Rev Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13045-022-01350-z","volume":"15","author":"Qin R.","year":"2022","unstructured":"Qin R.; You F.M.; Zhao Q.; Xie X.; Peng C.; Zhan G.; Han B.; Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: From molecular mechanisms to potential therapeutic targets. J Hematol Oncol  2022,15(1),133","journal-title":"J Hematol Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"601710","DOI":"10.3389\/fonc.2020.601710","volume":"10","author":"Suresh D.","year":"2020","unstructured":"Suresh D.; Srinivas A.N.; Kumar D.P.; Etiology of hepatocellular carcinoma: Special focus on fatty liver disease. Front Oncol  2020,10,601710","journal-title":"Front Oncol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/carcin\/bgv035","volume":"36","author":"Casey S.C.","year":"2015","unstructured":"Casey S.C.; Vaccari M.; Al-Mulla F.; Al-Temaimi R.; Amedei A.; Barcellos-Hoff M.H.; Brown D.G.; Chapellier M.; Christopher J.; Curran C.S.; Forte S.; Hamid R.A.; Heneberg P.; Koch D.C.; Krishnakumar P.K.; Laconi E.; Maguer-Satta V.; Marongiu F.; Memeo L.; Mondello C.; Raju J.; Roman J.; Roy R.; Ryan E.P.; Ryeom S.; Salem H.K.; Scovassi A.I.; Singh N.; Soucek L.; Vermeulen L.; Whitfield J.R.; Woodrick J.; Colacci A.M.; Bisson W.H.; Felsher D.W.; The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis  2015,36(Suppl. 1),S160-S183","journal-title":"Carcinogenesis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jox11030007","volume":"11","author":"Esteves F.","year":"2021","unstructured":"Esteves F.; Rueff J.; Kranendonk M.; The central role of cytochrome P450 in xenobiotic metabolism\u2014A brief review on a fascinating enzyme family. J Xenobiot  2021,11(3),94-114","journal-title":"J Xenobiot"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"Farazi P.A.","year":"2006","unstructured":"Farazi P.A.; DePinho R.A.; Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer  2006,6(9),674-687","journal-title":"Nat Rev Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1002\/cpz1.211","volume":"1","author":"Uehara T.","year":"2021","unstructured":"Uehara T.; Pogribny I.P.; Rusyn I.; The DEN and CCl4\u2010Induced mouse model of fibrosis and inflammation\u2010associated hepatocellular carcinoma. Curr Protoc  2021,1(8),e211","journal-title":"Curr Protoc"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9472939","volume":"2018","author":"Arboatti A.S.","year":"2018","unstructured":"Arboatti A.S.; Lambertucci F.; Sedlmeier M.G.; Pisani G.; Monti J.; \u00c1lvarez M.L.; Franc\u00e9s D.E.A.; Ronco M.T.; Carnovale C.E.; Diethylnitrosamine increases proliferation in early stages of hepatic carcinogenesis in insulin-treated type 1 diabetic mice. BioMed Res Int  2018,2018,1-10","journal-title":"BioMed Res Int"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"114845","DOI":"10.1016\/j.bcp.2021.114845","volume":"195","author":"M\u00e1rquez-Quiroga L.V.","year":"2022","unstructured":"M\u00e1rquez-Quiroga L.V.; Arellanes-Robledo J.; V\u00e1squez-Garz\u00f3n V.R.; Villa-Trevi\u00f1o S.; Muriel P.; Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma. Biochem Pharmacol  2022,195,114845","journal-title":"Biochem Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3892\/mmr.2016.6046","volume":"15","author":"Ledda C.","year":"2017","unstructured":"Ledda C.; Loreto C.; Zammit C.; Marconi A.; Fago L.; Matera S.; Costanzo V.; Sanz\u00e0 G.F.; Palmucci S.; Ferrante M.; Costa C.; Fenga C.; Biondi A.; Pomara C.; Rapisarda V.; Non-infective occupational risk factors for hepatocellular carcinoma: A review. Mol Med Rep  2017,15(2),511-533","journal-title":"Mol Med Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"121994","DOI":"10.1016\/j.lfs.2023.121994","volume":"330","author":"Romualdo G.R.","year":"2023","unstructured":"Romualdo G.R.; Heidor R.; Bacil G.P.; Moreno F.S.; Barbisan L.F.; Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks. Life Sci  2023,330,121994","journal-title":"Life Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"104367","DOI":"10.1016\/j.phrs.2019.104367","volume":"147","author":"Dey P.","year":"2019","unstructured":"Dey P.; Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacol Res  2019,147,104367","journal-title":"Pharmacol Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/bjc.1979.266","volume":"40","author":"Margison G.P.","year":"1979","unstructured":"Margison G.P.; Curtin N.J.; Snell K.; Craig A.W.; Effect of chronic N,N-diethylnitrosamine on the excision of O6-ethylguanine from rat liver DNA. Br J Cancer  1979,40(5),809-813","journal-title":"Br J Cancer"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jhep.2018.06.009","volume":"69","author":"Connor F.","year":"2018","unstructured":"Connor F.; Rayner T.F.; Aitken S.J.; Feig C.; Lukk M.; Santoyo-Lopez J.; Odom D.T.; Mutational landscape of a chemically-induced mouse model of liver cancer. J Hepatol  2018,69(4),840-850","journal-title":"J Hepatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2013.03.039","volume":"434","author":"Arul D.","year":"2013","unstructured":"Arul D.; Subramanian P.; Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biochem Biophys Res Commun  2013,434(2),203-209","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3889\/oamjms.2017.101","volume":"5","author":"Unsal V.","year":"2017","unstructured":"Unsal V.; Belge-Kuruta\u00c5\u0178, E.\u00c3. Experimental hepatic carcinogenesis: Oxidative stress and natural antioxidants. Open Access Maced J Med Sci  2017,5(5),686-691","journal-title":"Open Access Maced J Med Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/ijms24054684","volume":"24","author":"Fahrer J.","year":"2023","unstructured":"Fahrer J.; Christmann M.; DNA alkylation damage by nitrosamines and relevant dna repair pathways. Int J Mol Sci  2023,24(5),4684","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3835(95)04034-X","volume":"99","author":"Sheweita S.A.","year":"1996","unstructured":"Sheweita S.A.; Mostafa M.H.; N-Nitrosamines and their effects on the level of glutathione, glutathione reductase and glutathione S-transferase activities in the liver of male mice. Cancer Lett  1996,99(1),29-34","journal-title":"Cancer Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","volume":"39","author":"Yang Y.","year":"2019","unstructured":"Yang Y.; Kim S.; Seki E.; Inflammation and liver cancer: Molecular mechanisms and therapeutic targets. Semin Liver Dis  2019,39(1),26-42","journal-title":"Semin Liver Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1749-6632.2009.03704.x","volume":"1155","author":"Berasain C.","year":"2009","unstructured":"Berasain C.; Castillo J.; Perugorria M.J.; Latasa M.U.; Prieto J.; Avila M.A.; Inflammation and liver cancer: New molecular links. Ann N Y Acad Sci  2009,1155(1),206-221","journal-title":"Ann N Y Acad Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1367364","DOI":"10.3389\/fonc.2024.1367364","volume":"14","author":"Zhao Z.","year":"2024","unstructured":"Zhao Z.; Cui T.; Wei F.; Zhou Z.; Sun Y.; Gao C.; Xu X.; Zhang H.; Wnt\/\u03b2-Catenin signaling pathway in hepatocellular carcinoma: Pathogenic role and therapeutic target. Front Oncol  2024,14,1367364","journal-title":"Front Oncol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2013.08.004","volume":"183","author":"Hsu S.","year":"2013","unstructured":"Hsu S.; Wang B.; Kutay H.; Bid H.; Shreve J.; Zhang X.; Costinean S.; Bratasz A.; Houghton P.; Ghoshal K.; Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol  2013,183(6),1719-1730","journal-title":"Am J Pathol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.25747","volume":"56","author":"Callegari E.","year":"2012","unstructured":"Callegari E.; Elamin B.K.; Giannone F.; Milazzo M.; Altavilla G.; Fornari F.; Giacomelli L.; D\u2019Abundo L.; Ferracin M.; Bassi C.; Zagatti B.; Corr\u00e0 F.; Miotto E.; Lupini L.; Bolondi L.; Gramantieri L.; Croce C.M.; Sabbioni S.; Negrini M.; Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology  2012,56(3),1025-1033","journal-title":"Hepatology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biochi.2017.05.017","volume":"140","author":"Perumal N.","year":"2017","unstructured":"Perumal N.; Perumal M.; Halagowder D.; Sivasithamparam N.; Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo\/Yap and TGF-\u03b21\/Smad signaling. Biochimie  2017,140,10-19","journal-title":"Biochimie"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3748\/wjg.v28.i27.3346","volume":"28","author":"Zhang C.Y.","year":"2022","unstructured":"Zhang C.Y.; Liu S.; Yang M.; Regulatory T.; Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy. World J Gastroenterol  2022,28(27),3346-3358","journal-title":"World J Gastroenterol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","volume":"48","author":"Newell P.","year":"2008","unstructured":"Newell P.; Villanueva A.; Friedman S.L.; Koike K.; Llovet J.M.; Experimental models of hepatocellular carcinoma. J Hepatol  2008,48(5),858-879","journal-title":"J Hepatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"902820","DOI":"10.3389\/fonc.2022.902820","volume":"12","author":"Liu S.","year":"2022","unstructured":"Liu S.; Huang F.; Ru G.; Wang Y.; Zhang B.; Chen X.; Chu L.; Mouse models of hepatocellular carcinoma: Classification, advancement, and application. Front Oncol  2022,12,902820","journal-title":"Front Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/713611034","volume":"33","author":"Weber L.W.D.","year":"2003","unstructured":"Weber L.W.D.; Boll M.; Stampfl A.; Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol  2003,33(2),105-136","journal-title":"Crit Rev Toxicol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0192623312468517","volume":"41","author":"Wahlang B.","year":"2013","unstructured":"Wahlang B.; Beier J.I.; Clair H.B.; Bellis-Jones H.J.; Falkner K.C.; McClain C.J.; Cave M.C.; Toxicant-associated steatohepatitis. Toxicol Pathol  2013,41(2),343-360","journal-title":"Toxicol Pathol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0300-483X(01)00473-5","volume":"169","author":"Sheweita S.A.","year":"2001","unstructured":"Sheweita S.A.; Abd El-Gabar M.; Bastawy M.; Carbon tetrachloride changes the activity of cytochrome P450 system in the liver of male rats: Role of antioxidants. Toxicology  2001,169(2),83-92","journal-title":"Toxicology"},{"key":"ref=55","author":"Al Amin A.S.M.","year":"2025","unstructured":"Al Amin A.S.M.; Menezes, Ritesh G. Carbon tetrachloride toxicity. StatPearls  2025","journal-title":"StatPearls"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1472-6882-12-178","volume":"12","author":"Khan R.A.","year":"2012","unstructured":"Khan R.A.; Khan M.R.; Sahreen S.; CCl4-induced hepatotoxicity: Protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Altern Med  2012,12(1),178","journal-title":"BMC Complement Altern Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/taap.1999.8788","volume":"161","author":"Hartley D.P.","year":"1999","unstructured":"Hartley D.P.; Kolaja K.L.; Reichard J.; Petersen D.R.; 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: Immunochemical detection and lobular localization. Toxicol Appl Pharmacol  1999,161(1),23-33","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","volume":"16","author":"Lee Y.S.","year":"2023","unstructured":"Lee Y.S.; Seki E.; In vivo and in vitro models to study liver fibrosis: Mechanisms and limitations. Cell Mol Gastroenterol Hepatol  2023,16(3),355-367","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"Roehlen N.","year":"2020","unstructured":"Roehlen N.; Crouchet E.; Baumert T.F.; Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells  2020,9(4),875","journal-title":"Cells"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"651444","DOI":"10.3389\/fphar.2021.651444","volume":"12","author":"Li R.","year":"2021","unstructured":"Li R.; Yang W.; Yin Y.; Ma X.; Zhang P.; Tao K.; 4-OI attenuates carbon tetrachloride-induced hepatic injury via regulating oxidative stress and the inflammatory response. Front Pharmacol  2021,12,651444","journal-title":"Front Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"Gandhi C.R.","year":"2017","unstructured":"Gandhi C.R.; Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol  2017,67(5),1104-1105","journal-title":"J Hepatol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"Khomich O.","year":"2019","unstructured":"Khomich O.; Ivanov A.V.; Bartosch B.; Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells  2019,9(1),24","journal-title":"Cells"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/reveh-2020-0048","volume":"36","author":"Unsal V.","year":"2021","unstructured":"Unsal V.; Cicek M.; Sabancilar \u0130.; Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Rev Environ Health  2021,36(2),279-295","journal-title":"Rev Environ Health"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"LeFort K.R.","year":"2024","unstructured":"LeFort K.R.; Rungratanawanich W.; Song B.J.; Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci  2024,81(1),34","journal-title":"Cell Mol Life Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1111\/febs.16336","volume":"289","author":"G Bardallo R.","year":"2022","unstructured":"G Bardallo R.; Panisello-Rosell\u00f3, A.; Sanchez-Nuno, S.; Alva, N.; Rosell\u00f3-Catafau, J.; Carbonell, T. Nrf2 and oxidative stress in liver ischemia\/reperfusion injury. FEBS J  2022,289(18),5463-5479","journal-title":"FEBS J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/antiox9111151","volume":"9","author":"Jaganjac M.","year":"2020","unstructured":"Jaganjac M.; Milkovic L.; Sunjic S.B.; Zarkovic N.; The NRF2, Thioredoxin, and glutathione system in tumorigenesis and anticancer therapies. Antioxidants  2020,9(11),1151","journal-title":"Antioxidants"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"Tak P.P.","year":"2001","unstructured":"Tak P.P.; Firestein G.S.; NF-\u03baB: A key role in inflammatory diseases. J Clin Invest  2001,107(1),7-11","journal-title":"J Clin Invest"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"155663","DOI":"10.1016\/j.prp.2024.155663","volume":"263","author":"Munakarmi S.","year":"2024","unstructured":"Munakarmi S.; Gurau Y.; Shrestha J.; Chand L.; Park H.S.; Lee G.H.; Jeong Y.J.; trans-chalcone ameliorates CCl4-induced acute liver injury by suppressing endoplasmic reticulum stress, oxidative stress and inflammation. Pathol Res Pract  2024,263,155663","journal-title":"Pathol Res Pract"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.3390\/ijms21155230","volume":"21","author":"Borkham-Kamphorst E.","year":"2020","unstructured":"Borkham-Kamphorst E.; Haas U.; Van de Leur E.; Trevanich A.; Weiskirchen R.; Chronic carbon tetrachloride applications induced hepatocyte apoptosis in lipocalin 2 null mice through endoplasmic reticulum stress and unfolded protein response. Int J Mol Sci  2020,21(15),5230","journal-title":"Int J Mol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.omtn.2018.11.018","volume":"14","author":"Callegari E.","year":"2019","unstructured":"Callegari E.; Domenicali M.; Shankaraiah R.C.; D\u2019Abundo L.; Guerriero P.; Giannone F.; Baldassarre M.; Bassi C.; Elamin B.K.; Zagatti B.; Ferracin M.; Fornari F.; Altavilla G.; Blandamura S.; Silini E.M.; Gramantieri L.; Sabbioni S.; Negrini M.; MicroRNA-based prophylaxis in a mouse model of cirrhosis and liver cancer. Mol Ther Nucleic Acids  2019,14,239-250","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"117598","DOI":"10.1016\/j.biopha.2024.117598","volume":"180","author":"Li J.","year":"2024","unstructured":"Li J.; Cheng X.; Huang D.; Cui R.; The regulatory role of mitotic catastrophe in hepatocellular carcinoma drug resistance mechanisms and its therapeutic potential. Biomed Pharmacother  2024,180,117598","journal-title":"Biomed Pharmacother"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e2493","DOI":"10.1371\/journal.pone.0002493","volume":"3","author":"Beer S.","year":"2008","unstructured":"Beer S.; Komatsubara K.; Bellovin D.I.; Kurobe M.; Sylvester K.; Felsher D.W.; Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis. PLoS One  2008,3(6),e2493","journal-title":"PLoS One"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/ijc.28610","volume":"134","author":"Chappell G.","year":"2014","unstructured":"Chappell G.; Kutanzi K.; Uehara T.; Tryndyak V.; Hong H.H.; Hoenerhoff M.; Beland F.A.; Rusyn I.; Pogribny I.P.; Genetic and epigenetic changes in fibrosis\u2010associated hepatocarcinogenesis in mice. Int J Cancer  2014,134(12),2778-2788","journal-title":"Int J Cancer"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"111480","DOI":"10.1016\/j.cbi.2025.111480","volume":"413","author":"Lu L.","year":"2025","unstructured":"Lu L.; Ma Y.; Tao Q.; Xie J.; Liu X.; Wu Y.; Zhang Y.; Xie X.; Liu M.; Jin Y.; Hypoxia-inducible factor-1 alpha (HIF-1\u03b1) inhibitor AMSP-30 m attenuates CCl4-induced liver fibrosis in mice by inhibiting the sonic hedgehog pathway. Chem Biol Interact  2025,413,111480","journal-title":"Chem Biol Interact"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"584048","DOI":"10.3389\/fimmu.2020.584048","volume":"11","author":"Ikeno Y.","year":"2020","unstructured":"Ikeno Y.; Ohara D.; Takeuchi Y.; Watanabe H.; Kondoh G.; Taura K.; Uemoto S.; Hirota K.; Foxp3+ regulatory T cells inhibit CCl4-induced liver inflammation and fibrosis by regulating tissue cellular immunity. Front Immunol  2020,11,584048","journal-title":"Front Immunol"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2013.008XX","volume":"1","year":"2016","unstructured":"Environmental exposures and hepatocellular carcinoma. J Clin Transl Hepatol  2016,1(2)","journal-title":"J Clin Transl Hepatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"117437","DOI":"10.1016\/j.ecoenv.2024.117437","volume":"290","author":"Wu X.","year":"2025","unstructured":"Wu X.; Zhang X.; Yu X.; Liang H.; Tang S.; Wang Y.; Exploring the association between air pollution and the incidence of liver cancers. Ecotoxicol Environ Saf  2025,290,117437","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/toxins14050307","volume":"14","author":"Shabeer S.","year":"2022","unstructured":"Shabeer S.; Asad S.; Jamal A.; Ali A.; Aflatoxin contamination, its impact and management strategies: An updated review. Toxins  2022,14(5),307","journal-title":"Toxins"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/carcin\/22.4.535","volume":"22","author":"Smela M.E.","year":"2001","unstructured":"Smela M.E.; Currier S.S.; Bailey E.A.; Essigmann J.M.; The chemistry and biology of aflatoxin B1: From mutational spectrometry to carcinogenesis. Carcinogenesis  2001,22(4),535-545","journal-title":"Carcinogenesis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","volume":"23","author":"Kew M.C.","year":"2003","unstructured":"Kew M.C.; Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int  2003,23(6),405-409","journal-title":"Liver Int"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"153983","DOI":"10.1016\/j.tox.2024.153983","volume":"509","author":"Moloi T.P.","year":"2024","unstructured":"Moloi T.P.; Ziqubu K.; Mazibuko-Mbeje S.E.; Mabaso N.H.; Ndlovu Z.; Aflatoxin B1-induced hepatotoxicity through mitochondrial dysfunction, oxidative stress, and inflammation as central pathological mechanisms: A review of experimental evidence. Toxicology  2024,509,153983","journal-title":"Toxicology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fphar.2019.00648","volume":"10","author":"Han J.","year":"2019","unstructured":"Han J.; Xian Z.; Zhang Y.; Liu J.; Liang A.; Systematic overview of aristolochic acids: Nephrotoxicity, carcinogenicity, and underlying mechanisms. Front Pharmacol  2019,10,648","journal-title":"Front Pharmacol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0940-2993(99)80033-5","volume":"51","author":"Stiborov\u00e1 M.","year":"1999","unstructured":"Stiborov\u00e1 M.; Frei E.; Breuer A.; Bieler C.A.; Schmeiser H.H.; Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxicol Pathol  1999,51(4-5),421-427","journal-title":"Exp Toxicol Pathol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ki.2011.371","volume":"81","author":"Jelakovi\u0107 B.","year":"2012","unstructured":"Jelakovi\u0107 B.; Karanovi\u0107 S.; Vukovi\u0107-Lela I.; Miller F.; Edwards K.L.; Nikoli\u0107 J.; Tomi\u0107 K.; Slade N.; Brdar B.; Turesky R.J.; Stipan\u010di\u0107 \u017d.; Dittrich D.; Grollman A.P.; Dickman K.G.; Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int  2012,81(6),559-567","journal-title":"Kidney Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/1477-3163.93700","volume":"11","author":"Brandt-Rauf P.","year":"2012","unstructured":"Brandt-Rauf P.; Long C.; Kovvali G.; Li Y.; Monaco R.; Marion M.J.; Plastics and carcinogenesis: The example of vinyl chloride. J Carcinog  2012,11(1),5","journal-title":"J Carcinog"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.3748\/wjg.v25.i33.4885","volume":"25","author":"Fedeli U.","year":"2019","unstructured":"Fedeli U.; Girardi P.; Mastrangelo G.; Occupational exposure to vinyl chloride and liver diseases. World J Gastroenterol  2019,25(33),4885-4891","journal-title":"World J Gastroenterol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"153054","DOI":"10.1016\/j.tox.2021.153054","volume":"466","author":"Eti N.A.","year":"2022","unstructured":"Eti N.A.; Flor S.; Iqbal K.; Scott R.L.; Klenov V.E.; Gibson-Corley K.N.; Soares M.J.; Ludewig G.; Robertson L.W.; PCB126 induced toxic actions on liver energy metabolism is mediated by AhR in rats. Toxicology  2022,466,153054","journal-title":"Toxicology"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.taap.2013.05.034","volume":"272","author":"G\u00e4hrs M.","year":"2013","unstructured":"G\u00e4hrs M.; Roos R.; Andersson P.L.; Schrenk D.; Role of the nuclear xenobiotic receptors CAR and PXR in induction of cytochromes P450 by non-dioxinlike polychlorinated biphenyls in cultured rat hepatocytes. Toxicol Appl Pharmacol  2013,272(1),77-85","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/foods10071443","volume":"10","author":"Ram\u00edrez Carnero A.","year":"2021","unstructured":"Ram\u00edrez Carnero A.; Lestido-Cardama A.; Vazquez Loureiro P.; Barbosa-Pereira L.; Rodr\u00edguez Bernaldo de Quir\u00f3s A.; Send\u00f3n R.; Presence of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in food contact materials (FCM) and its migration to food. Foods  2021,10(7),1443","journal-title":"Foods"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"154167","DOI":"10.1016\/j.tox.2025.154167","volume":"515","author":"Choi M.A.","year":"2025","unstructured":"Choi M.A.; Rose S.; Langou\u00ebt S.; Per- and polyfluoroalkyl substances as potentiators of hepatotoxicity in an exposome framework: Current challenges of environmental toxicology. Toxicology  2025,515,154167","journal-title":"Toxicology"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"046001","DOI":"10.1289\/EHP10092","volume":"130","author":"Costello E.","year":"2022","unstructured":"Costello E.; Rock S.; Stratakis N.; Eckel S.P.; Walker D.I.; Valvi D.; Cserbik D.; Jenkins T.; Xanthakos S.A.; Kohli R.; Sisley S.; Vasiliou V.; La Merrill M.A.; Rosen H.; Conti D.V.; McConnell R.; Chatzi L.; Exposure to per- and polyfluoroalkyl substances and markers of liver injury: A systematic review and meta-analysis. Environ Health Perspect  2022,130(4),046001","journal-title":"Environ Health Perspect"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"Bhatti J.S.","year":"2017","unstructured":"Bhatti J.S.; Bhatti G.K.; Reddy P.H.; Mitochondrial dysfunction and oxidative stress in metabolic disorders \u2014 A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis  2017,1863(5),1066-1077","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.toxrep.2025.101993","volume":"14","author":"Khaleda L.","year":"2025","unstructured":"Khaleda L.; Alam M.M.; Tasnim Z.; Ezaj M.M.A.; Apu M.A.R.; Akter R.; Bakar M.A.; Alam M.J.; Chowdhury R.H.; Datta A.; Shawon I.I.; Rahman M.Z.; Al-Forkan M.; Detrimental effects of chronic arsenic exposure through daily diet on hepatic and renal health: An animal model study. Toxicol Rep  2025,14,101993","journal-title":"Toxicol Rep"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/epi.09.45","volume":"2","author":"Reichard J.F.","year":"2010","unstructured":"Reichard J.F.; Puga A.; Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics  2010,2(1),87-104","journal-title":"Epigenomics"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s11604-015-0479-1","volume":"33","author":"Takekawa S.","year":"2015","unstructured":"Takekawa S.; Ueda Y.; Hiramatsu Y.; Komiyama K.; Munechika, H. History note: Tragedy of thorotrast. Jpn J Radiol  2015,33(11),718-722","journal-title":"Jpn J Radiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ijc.10726","volume":"102","author":"Liu D.","year":"2002","unstructured":"Liu D.; Momoi H.; Li L.; Ishikawa Y.; Fukumoto M.; Microsatellite instability in thorotrast\u2010induced human intrahepatic cholangiocarcinoma. Int J Cancer  2002,102(4),366-371","journal-title":"Int J Cancer"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0531-5131(01)00756-7","volume":"1236","author":"Ishikawa Y.","year":"2002","unstructured":"Ishikawa Y.; Wada I.; Fukumoto M.; Cancers induced by alpha particles from thorotrast. Int Congr Ser  2002,1236,191-194","journal-title":"Int Congr Ser"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/biomedicines6040106","volume":"6","author":"Teschke R.","year":"2018","unstructured":"Teschke R.; Alcoholic liver disease: Alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects. Biomedicines  2018,6(4),106","journal-title":"Biomedicines"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","volume":"3","author":"Setshedi M.","year":"2010","unstructured":"Setshedi M.; Wands J.R.; de la Monte S.M.; Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev  2010,3(3),178-185","journal-title":"Oxid Med Cell Longev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","volume":"20","author":"Ceni E.","year":"2014","unstructured":"Ceni E.; Mello T.; Galli A.; Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterol  2014,20(47),17756-17772","journal-title":"World J Gastroenterol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"Gao B.","year":"2011","unstructured":"Gao B.; Bataller R.; Alcoholic liver disease: Pathogenesis and new therapeutic targets. Gastroenterology  2011,141(5),1572-1585","journal-title":"Gastroenterology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2004.tb03162.x","volume":"95","author":"Shimada T.","year":"2004","unstructured":"Shimada T.; Fujii-Kuriyama Y.; Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1. Cancer Sci  2004,95(1),1-6","journal-title":"Cancer Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1289\/ehp.1408524","volume":"123","author":"Ba Q.","year":"2015","unstructured":"Ba Q.; Li J.; Huang C.; Qiu H.; Li J.; Chu R.; Zhang W.; Xie D.; Wu Y.; Wang H.; Effects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-\u03baB signaling. Environ Health Perspect  2015,123(3),246-254","journal-title":"Environ Health Perspect"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3390\/cells11142209","volume":"11","author":"Muhammad N.","year":"2022","unstructured":"Muhammad N.; Usmani D.; Tarique M.; Naz H.; Ashraf M.; Raliya R.; Tabrez S.; Zughaibi T.A.; Alsaieedi A.; Hakeem I.J.; Suhail M.; The role of natural products and their multitargeted approach to treat solid cancer. Cells  2022,11(14),2209","journal-title":"Cells"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/cancers14246203","volume":"14","author":"Asma S.T.","year":"2022","unstructured":"Asma S.T.; Acaroz U.; Imre K.; Morar A.; Shah S.R.A.; Hussain S.Z.; Arslan-Acaroz D.; Demirbas H.; Hajrulai-Musliu Z.; Istanbullugil F.R.; Soleimanzadeh A.; Morozov D.; Zhu K.; Herman V.; Ayad A.; Athanassiou C.; Ince S.; Natural products\/bioactive compounds as a source of anticancer drugs. Cancers  2022,14(24),6203","journal-title":"Cancers"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/medicines5030093","volume":"5","author":"Tungmunnithum D.","year":"2018","unstructured":"Tungmunnithum D.; Thongboonyou A.; Pholboon A.; Yangsabai A.; Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: An overview. Medicines  2018,5(3),93","journal-title":"Medicines"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1116532","DOI":"10.3389\/fonc.2023.1116532","volume":"13","author":"Wang Y.","year":"2023","unstructured":"Wang Y.; Li J.; Xia L.; Plant-derived natural products and combination therapy in liver cancer. Front Oncol  2023,13,1116532","journal-title":"Front Oncol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/B978-0-12-804274-8.00049-7","author":"Reyes-Gordillo K.","year":"2017","unstructured":"Reyes-Gordillo K.; Shah R.; Lakshman M.R.; Flores-Beltr\u00e1n R.E.; Muriel P.; Hepatoprotective properties of curcumin. Liver Pathophysiology  2017,687-704","journal-title":"Liver Pathophysiology"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.3892\/etm.2018.5805","volume":"15","author":"Wang J.","year":"2018","unstructured":"Wang J.; Wang C.; Bu G.; Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase\/protein kinase B\/mammalian target of rapamycin signaling pathway. Exp Ther Med  2018,15(4),3650-3658","journal-title":"Exp Ther Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"13689","DOI":"10.3390\/ijms232213689","volume":"23","author":"Jang J.Y.","year":"2022","unstructured":"Jang J.Y.; Im E.; Kim N.D.; Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: A review. Int J Mol Sci  2022,23(22),13689","journal-title":"Int J Mol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1389179","DOI":"10.3389\/fphar.2024.1389179","volume":"15","author":"Xiong F.","year":"2024","unstructured":"Xiong F.; Zhang Y.; Li T.; Tang Y.; Song S.Y.; Zhou Q.; Wang Y.; A detailed overview of quercetin: Implications for cell death and liver fibrosis mechanisms. Front Pharmacol  2024,15,1389179","journal-title":"Front Pharmacol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","volume":"6","author":"Vargas-Mendoza N.","year":"2014","unstructured":"Vargas-Mendoza N.; Madrigal-Santill\u00e1n E.; Morales-Gonz\u00e1lez A.; Esquivel-Soto J.; Esquivel-Chirino C.; Garc\u00eda-Luna Y.; Gonz\u00e1lez-Rubio, M.; Gayosso-de-Lucio, J.A.; Morales-Gonz\u00e1lez, J.A. Hepatoprotective effect of silymarin. World J Hepatol  2014,6(3),144-149","journal-title":"World J Hepatol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e26701","DOI":"10.1016\/j.heliyon.2024.e26701","volume":"10","author":"Rauf A.","year":"2024","unstructured":"Rauf A.; Wilairatana P.; Joshi P.B.; Ahmad Z.; Olatunde A.; Hafeez N.; Hemeg H.A.; Mubarak M.S.; Revisiting luteolin: An updated review on its anticancer potential. Heliyon  2024,10(5),e26701","journal-title":"Heliyon"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.3390\/molecules27186051","volume":"27","author":"Rahmani A.H.","year":"2022","unstructured":"Rahmani A.H.; Alsahli M.A.; Almatroudi A.; Almogbel M.A.; Khan A.A.; Anwar S.; Almatroodi S.A.; The Potential role of apigenin in cancer prevention and treatment. Molecules  2022,27(18),6051","journal-title":"Molecules"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1475-2867-14-49","volume":"14","author":"Yu R.","year":"2014","unstructured":"Yu R.; Zhang Z.; Wang B.; Jiang H.; Cheng L.; Shen L.; Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation. Cancer Cell Int  2014,14(1),49","journal-title":"Cancer Cell Int"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"106326","DOI":"10.1016\/j.fitote.2024.106326","volume":"180","author":"Yu L.","year":"2025","unstructured":"Yu L.; Shen N.; Ren J.; Xin H.; Cui Y.; Resource distribution, pharmacological activity, toxicology and clinical drugs of \u03b2-Carboline alkaloids: An updated and systematic review. Fitoterapia  2025,180,106326","journal-title":"Fitoterapia"},{"key":"ref=117","doi-asserted-by":"publisher","DOI":"10.31031\/MADD.2020.03.000554","volume":"3","author":"Nagesh N.","year":"2020","unstructured":"Nagesh N.; Recent insights into \u03b2-carboline alkaloids with anticancer potential. Modern Approaches Drug Des  2020,3(1)","journal-title":"Modern Approaches Drug Des"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"117438","DOI":"10.1016\/j.biopha.2024.117438","volume":"180","author":"Hu J.","year":"2024","unstructured":"Hu J.; Li Y.; Xie X.; Song Y.; Yan W.; Luo Y.; Jiang Y.; The therapeutic potential of andrographolide in cancer treatment. Biomed Pharmacother  2024,180,117438","journal-title":"Biomed Pharmacother"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"558741","DOI":"10.3389\/fphar.2020.558741","volume":"11","author":"Shi J.","year":"2020","unstructured":"Shi J.; Li J.; Xu Z.; Chen L.; Luo R.; Zhang C.; Gao F.; Zhang J.; Fu C.; Celastrol: A review of useful strategies overcoming its limitation in anticancer application. Front Pharmacol  2020,11,558741","journal-title":"Front Pharmacol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"104460","DOI":"10.1016\/j.fbio.2024.104460","volume":"60","author":"Dong M.","year":"2024","unstructured":"Dong M.; Cui Q.; Li Y.; Li Y.; Chang Q.; Bai R.; Wei M.; zhao, L.; Chen, Q. Ursolic acid suppresses fatty liver-associated hepatocellular carcinoma by regulating lipid metabolism. Food Biosci  2024,60,104460","journal-title":"Food Biosci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e921606","DOI":"10.12659\/MSM.921606","volume":"26","author":"Zhou W.","year":"2020","unstructured":"Zhou W.; Zeng X.; Wu X.; Effect of Oleanolic Acid on Apoptosis and Autophagy of SMMC-7721 Hepatoma Cells. Med Sci Monit  2020,26,e921606","journal-title":"Med Sci Monit"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"795548","DOI":"10.3389\/fonc.2021.795548","volume":"11","author":"Zheng Y.","year":"2022","unstructured":"Zheng Y.; Zhang W.; Xu L.; Zhou H.; Yuan M.; Xu H.; Recent progress in understanding the action of natural compounds at novel therapeutic drug targets for the treatment of liver cancer. Front Oncol  2022,11,795548","journal-title":"Front Oncol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/2394-5079.2018.29","volume":"4","author":"Fu Y.","year":"2018","unstructured":"Fu Y.; Chung F.L.; Oxidative stress and hepatocarcinogenesis. Hepatoma Res  2018,4(8),39","journal-title":"Hepatoma Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"106131","DOI":"10.1016\/j.intimp.2019.106131","volume":"80","author":"Ibrahim S.G.","year":"2020","unstructured":"Ibrahim S.G.; El-Emam S.Z.; Mohamed E.A.; Abd Ellah M.F.; Dimethyl fumarate and curcumin attenuate hepatic ischemia\/reperfusion injury via Nrf2\/HO-1 activation and anti-inflammatory properties. Int Immunopharmacol  2020,80,106131","journal-title":"Int Immunopharmacol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/nu10070855","volume":"10","author":"Farzaei M.H.","year":"2018","unstructured":"Farzaei M.H.; Zobeiri M.; Parvizi F.; El-Senduny F.F.; Marmouzi I.; Coy-Barrera E.; Naseri R.; Nabavi S.M.; Rahimi R.; Abdollahi M.; Curcumin in liver diseases: A systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients  2018,10(7),855","journal-title":"Nutrients"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","volume":"63","author":"Marquardt J.U.","year":"2015","unstructured":"Marquardt J.U.; Gomez-Quiroz L.; Arreguin Camacho L.O.; Pinna F.; Lee Y.H.; Kitade M.; Dom\u00ednguez M.P.; Castven D.; Breuhahn K.; Conner E.A.; Galle P.R.; Andersen J.B.; Factor V.M.; Thorgeirsson S.S.; Curcumin effectively inhibits oncogenic NF-\u03baB signaling and restrains stemness features in liver cancer. J Hepatol  2015,63(3),661-669","journal-title":"J Hepatol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.prmcm.2023.100233","volume":"6","author":"Bhattacharya S.","year":"2023","unstructured":"Bhattacharya S.; Perris A.; Jawed J.J.; Hoda M.; Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action. Pharmacol Res Mod Chin Med  2023,6,100233","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/138920112798868575","volume":"13","author":"Mbimba T.","year":"2012","unstructured":"Mbimba T.; Awale P.; Bhatia D.; Geldenhuys W.J.; Darvesh A.S.; Carroll R.T.; Bishayee A.; Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Curr Pharm Biotechnol  2012,13(1),229-234","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejphar.2006.11.014","volume":"557","author":"Garc\u00eda-Mediavilla V.","year":"2007","unstructured":"Garc\u00eda-Mediavilla V.; Crespo I.; Collado P.S.; Esteller A.; S\u00e1nchez-Campos S.; Tu\u00f1\u00f3n M.J.; Gonz\u00e1lez-Gallego J.; The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol  2007,557(2-3),221-229","journal-title":"Eur J Pharmacol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3892\/mco.2024.2779","volume":"21","author":"Shaharudin N.S.","year":"2024","unstructured":"Shaharudin N.S.; Surindar Singh G.K.; Kek T.; Sultan S.; Targeting signaling pathways with andrographolide in cancer therapy (Review). Mol Clin Oncol  2024,21(5),81","journal-title":"Mol Clin Oncol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.3390\/molecules27196401","volume":"27","author":"Bhadra K.","year":"2022","unstructured":"Bhadra K.; A mini review on molecules inducing caspase-independent cell death: A new route to cancer therapy. Molecules  2022,27(19),6401","journal-title":"Molecules"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1382142","DOI":"10.3389\/fonc.2024.1382142","volume":"14","author":"Hu Y.","year":"2024","unstructured":"Hu Y.; Yu X.; Yang L.; Xue G.; Wei Q.; Han Z.; Chen H.; Research progress on the antitumor effects of harmine. Front Oncol  2024,14,1382142","journal-title":"Front Oncol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3892\/ol.2017.7495","volume":"15","author":"Xu B.","year":"2018","unstructured":"Xu B.; Li M.; Yu Y.; He J.; Hu S.; Pan M.; Lu S.; Liao K.; Pan Z.; Zhou Y.; Zhu J.; Effects of harmaline on cell growth of human liver cancer through the p53\/p21 and Fas\/FasL signaling pathways. Oncol Lett  2018,15(2),1931-1936","journal-title":"Oncol Lett"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"105705","DOI":"10.1016\/j.jff.2023.105705","volume":"108","author":"Meybodi S.M.","year":"2023","unstructured":"Meybodi S.M.; Rezaei P.; Faraji N.; Jamehbozorg K.; Ashna S.; Shokri F.; Goleij P.; Moradi S.; Kashian M.; Arefnezhad R.; Sahebkar A.; Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy. J Funct Foods  2023,108,105705","journal-title":"J Funct Foods"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/carcin\/bgi167","volume":"26","author":"Jung E.M.","year":"2005","unstructured":"Jung E.M.; Lim J.H.; Lee T.J.; Park J.W.; Choi K.S.; Kwon T.K.; Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis  2005,26(11),1905-1913","journal-title":"Carcinogenesis"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.bbagen.2006.09.010","volume":"1760","author":"Notas G.","year":"2006","unstructured":"Notas G.; Nifli A.P.; Kampa M.; Vercauteren J.; Kouroumalis E.; Castanas E.; Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta, Gen Subj  2006,1760(11),1657-1666","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"93039","DOI":"10.18632\/oncotarget.21750","volume":"8","author":"Ren B.","year":"2017","unstructured":"Ren B.; Liu H.; Gao H.; Liu S.; Zhang Z.; Fribley A.M.; Callaghan M.U.; Xu Z.; Zeng Q.; Li Y.; Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress\/UPR. Oncotarget  2017,8(54),93039-93050","journal-title":"Oncotarget"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/jcb.22869","volume":"111","author":"Wang N.","year":"2010","unstructured":"Wang N.; Feng Y.; Zhu M.; Tsang C.M.; Man K.; Tong Y.; Tsao S.W.; Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism. J Cell Biochem  2010,111(6),1426-1436","journal-title":"J Cell Biochem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"102022","DOI":"10.1016\/j.mcp.2025.102022","volume":"81","author":"Yuan B.","year":"2025","unstructured":"Yuan B.; Wang R.; Gao Z.; Mirzeei H.; Xiang A.D.; Guo F.; Silymarin plus doxorubicin exerts the anti-hepatocellular carcinoma effects via Wnt, apoptosis, autophagy and angiogenesis pathways. Mol Cell Probes  2025,81,102022","journal-title":"Mol Cell Probes"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3978\/j.issn.2304-3881.2013.06.06","volume":"2","author":"Zhan P.","year":"2013","unstructured":"Zhan P.; Qian Q.; Yu L-K.; Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: A meta-analysis. Hepatobiliary Surg Nutr  2013,2(3),148-155","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"20220618","DOI":"10.1515\/biol-2022-0618","volume":"18","author":"Wang X.","year":"2023","unstructured":"Wang X.; Tian Y.; Lin H.; Cao X.; Zhang Z.; Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3\/VEGF\/HIF-1\u03b1 signaling. Open Life Sci  2023,18(1),20220618","journal-title":"Open Life Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/nu13030933","volume":"13","author":"Izzo C.","year":"2021","unstructured":"Izzo C.; Annunziata M.; Melara G.; Sciorio R.; Dallio M.; Masarone M.; Federico A.; Persico M.; The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials. Nutrients  2021,13(3),933","journal-title":"Nutrients"},{"key":"ref=143","first-page":"4521","volume":"15","author":"Yu L.","year":"2023","unstructured":"Yu L.; Li T.; Zhang H.; Ma Z.; Wu S.; Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1\u03b1\/VEGF pathway. Am J Transl Res  2023,15(7),4521-4532","journal-title":"Am J Transl Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"113956","DOI":"10.1016\/j.biopha.2022.113956","volume":"156","author":"Ming T.","year":"2022","unstructured":"Ming T.; Tao Q.; Tang S.; Zhao H.; Yang H.; Liu M.; Ren S.; Xu H.; Curcumin: An epigenetic regulator and its application in cancer. Biomed Pharmacother  2022,156,113956","journal-title":"Biomed Pharmacother"},{"key":"ref=145","doi-asserted-by":"publisher","DOI":"10.3892\/ijfn.2020.1","volume":"1","author":"Mota S.R.S.","year":"2020","unstructured":"Mota S.R.S.; Kviecinski M.R.; Felipe K.B.; Grinevicius M.A.S.V.; Siminski T.; Almeida G.M.; Zeferino R.C.; Pich C.T.; Filho D.W.; Pedrosa, RC \u03b2-Carboline alkaloid harmine induces DNA damage and triggers apoptosis by a mitochondrial pathway: Study in silico, in vitro and in vivo. Int J Funct Nutr  2020,1(1)","journal-title":"Int J Funct Nutr"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bioorg.2015.11.005","volume":"64","author":"Shankaraiah N.","year":"2016","unstructured":"Shankaraiah N.; Jadala C.; Nekkanti S.; Senwar K.R.; Nagesh N.; Shrivastava S.; Naidu V.G.M.; Sathish M.; Kamal A.; Design and synthesis of C3-tethered 1,2,3-triazolo-\u03b2-carboline derivatives: Anticancer activity, DNA-binding ability, viscosity and molecular modeling studies. Bioorg Chem  2016,64,42-50","journal-title":"Bioorg Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.phymed.2018.03.040","volume":"43","author":"Chen Z.","year":"2018","unstructured":"Chen Z.; Huang C.; Ma T.; Jiang L.; Tang L.; Shi T.; Zhang S.; Zhang L.; Zhu P.; Li J.; Shen A.; Reversal effect of quercetin on multidrug resistance via FZD7\/\u03b2-catenin pathway in hepatocellular carcinoma cells. Phytomedicine  2018,43,37-45","journal-title":"Phytomedicine"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12935-022-02677-w","volume":"22","author":"Asgharian P.","year":"2022","unstructured":"Asgharian P.; Tazekand A.P.; Hosseini K.; Forouhandeh H.; Ghasemnejad T.; Ranjbar M.; Hasan M.; Kumar M.; Beirami S.M.; Tarhriz V.; Soofiyani S.R.; Kozhamzharova L.; Sharifi-Rad J.; Calina D.; Cho W.C.; Potential mechanisms of quercetin in cancer prevention: Focus on cellular and molecular targets. Cancer Cell Int  2022,22(1),257","journal-title":"Cancer Cell Int"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2174\/0929867331666230914090053","volume":"31","author":"Tong K.","year":"2024","unstructured":"Tong K.; Wang P.; Li Y.; Tong Y.; li, X.; Yan, S.; Hu, P. Resveratrol inhibits hepatocellular carcinoma progression through regulating exosome secretion. Curr Med Chem  2024,31(15),2107-2118","journal-title":"Curr Med Chem"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"9839","DOI":"10.1021\/jf403241s","volume":"61","author":"Chu Y.L.","year":"2013","unstructured":"Chu Y.L.; Ho C.T.; Chung J.G.; Raghu R.; Lo Y.C.; Sheen L.Y.; Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy. J Agric Food Chem  2013,61(41),9839-9848","journal-title":"J Agric Food Chem"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2009.02.124","volume":"381","author":"Liu W.","year":"2009","unstructured":"Liu W.; Huang X.F.; Qi Q.; Dai Q.S.; Yang L.; Nie F.F.; Lu N.; Gong D.D.; Kong L.Y.; Guo Q.L.; Asparanin A induces G2\/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Biochem Biophys Res Commun  2009,381(4),700-705","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s12010-024-05150-8","volume":"197","author":"Manivannan H.P.","year":"2025","unstructured":"Manivannan H.P.; Veeraraghavan V.P.; Francis A.P.; Prediction of multi-targeting pharmacological activity of bioactive compounds from medicinal plants against hepatocellular carcinoma through advanced network pharmacology and bioinformatics-based investigation. Appl Biochem Biotechnol  2025,197(5),2979-3007","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3892\/etm.2017.5637","author":"Cao Y.","year":"2017","unstructured":"Cao Y.; Cao J.; Yu B.; Wang S.; Liu L.; Tao L.; Sun W.; Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway. Exp Ther Med  2017,1894-1901","journal-title":"Exp Ther Med"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"173655","DOI":"10.1016\/j.ejphar.2020.173655","volume":"890","author":"Zhou M.","year":"2021","unstructured":"Zhou M.; Deng Y.; Liu M.; Liao L.; Dai X.; Guo C.; Zhao X.; He L.; Peng C.; Li Y.; The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol  2021,890,173655","journal-title":"Eur J Pharmacol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.3748\/wjg.15.4538","volume":"15","author":"Li Z.F.","year":"2009","unstructured":"Li Z.F.; Wang Z.D.; Ji Y.Y.; Zhang S.; Huang C.; Li J.; Xia X.M.; Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract. World J Gastroenterol  2009,15(36),4538-4546","journal-title":"World J Gastroenterol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"e0126725","DOI":"10.1371\/journal.pone.0126725","volume":"10","author":"Ku C.Y.","year":"2015","unstructured":"Ku C.Y.; Wang Y.R.; Lin H.Y.; Lu S.C.; Lin J.Y.; Corosolic acid inhibits hepatocellular carcinoma cell migration by targeting the VEGFR2\/SRC\/FAK pathway. PLoS One  2015,10(5),e0126725","journal-title":"PLoS One"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1002\/ptr.7240","volume":"35","author":"Jin M.","year":"2021","unstructured":"Jin M.; Kong L.; Han Y.; Zhang S.; Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5\u2010fluorouracil in vivo by increasing curcumin bioavailability. Phytother Res  2021,35(10),5823-5837","journal-title":"Phytother Res"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/ijms17101653","volume":"17","author":"Ashwaq A.A.","year":"2016","unstructured":"Ashwaq A.A.; Al-Qubaisi M.; Rasedee A.; Abdul A.; Taufiq-Yap Y.; Yeap S.; Inducing G2\/M cell cycle arrest and apoptosis through generation reactive oxygen species (ROS)-mediated mitochondria pathway in HT-29 cells by dentatin (DEN) and dentatin incorporated in Hydroxypropyl-\u03b2-Cyclodextrin (DEN-HP\u03b2CD). Int J Mol Sci  2016,17(10),1653","journal-title":"Int J Mol Sci"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"715762","DOI":"10.3389\/fcell.2021.715762","volume":"9","author":"Gao J.","year":"2021","unstructured":"Gao J.; Yin Z.; Wu Z.; Sheng Z.; Ma C.; Chen R.; Zhang X.; Tang K.; Fei J.; Cao Z.; Probing synergistic targets by natural compounds for hepatocellular carcinoma. Front Cell Dev Biol  2021,9,715762","journal-title":"Front Cell Dev Biol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.4161\/cbt.6.7.4317","volume":"6","author":"Xiao Y.","year":"2007","unstructured":"Xiao Y.; Feng-Qing Y.; Shao-Ping L.; Jian-Li G.; Guang H.; Sin-Cheng L.; Emilia C.L.; Kwok-Pui F.; Yi-Tao W.; Simon L.M-Y.; Furanodiene induces G2\/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Cancer Biol Ther  2007,6(7),1044-1050","journal-title":"Cancer Biol Ther"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-015-0168-2","volume":"15","author":"Chien S.T.","year":"2015","unstructured":"Chien S.T.; Shi M.D.; Lee Y.C.; Te C.C.; Shih Y.W.; Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC\/ERK signaling pathway in TPA-treated liver cancer HepG2 cells. Cancer Cell Int  2015,15(1),15","journal-title":"Cancer Cell Int"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1021\/jf201289e","volume":"59","author":"Huang G.J.","year":"2011","unstructured":"Huang G.J.; Deng J.S.; Huang S.S.; Hu M.L.; Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation. J Agric Food Chem  2011,59(13),7104-7113","journal-title":"J Agric Food Chem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","volume":"27","author":"Zhao Z.","year":"2019","unstructured":"Zhao Z.; Jin G.; Ge Y.; Guo Z.; Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology  2019,27(5),1021-1036","journal-title":"Inflammopharmacology"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.7314\/APJCP.2014.15.4.1745","volume":"15","author":"Li T.","year":"2014","unstructured":"Li T.; Xu W.S.; Wu G.S.; Chen X.P.; Wang Y.T.; Lu J.J.; Platycodin D.; Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells. Asian Pac J Cancer Prev  2014,15(4),1745-1749","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.etap.2019.103200","volume":"70","author":"Zhou R.","year":"2019","unstructured":"Zhou R.; Wu K.; Su M.; Li R.; Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma. Environ Toxicol Pharmacol  2019,70,103200","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s12013-014-0025-2","volume":"70","author":"Jiang Z.","year":"2014","unstructured":"Jiang Z.; Xiong J.; Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by psoralen from Psoralea corylifolia. Cell Biochem Biophys  2014,70(2),1075-1081","journal-title":"Cell Biochem Biophys"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/pharmaceutics15020712","volume":"15","author":"Sethi G.","year":"2023","unstructured":"Sethi G.; Rath P.; Chauhan A.; Ranjan A.; Choudhary R.; Ramniwas S.; Sak K.; Aggarwal D.; Rani I.; Tuli H.S.; Apoptotic mechanisms of quercetin in liver cancer: Recent trends and advancements. Pharmaceutics  2023,15(2),712","journal-title":"Pharmaceutics"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/1541-7786.MCR-17-0304","volume":"16","author":"Wani N.A.","year":"2018","unstructured":"Wani N.A.; Zhang B.; Teng K.; Barajas J.M.; Motiwala T.; Hu P.; Yu L.; Br\u00fcschweiler R.; Ghoshal K.; Jacob S.T.; Reprogramming of glucose metabolism by zerumbone suppresses hepatocarcinogenesis. Mol Cancer Res  2018,16(2),256-268","journal-title":"Mol Cancer Res"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"113688","DOI":"10.1016\/j.ejmech.2021.113688","volume":"224","author":"Luo B.","year":"2021","unstructured":"Luo B.; Song X.; A comprehensive overview of \u03b2-carbolines and its derivatives as anticancer agents. Eur J Med Chem  2021,224,113688","journal-title":"Eur J Med Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"113321","DOI":"10.1016\/j.ejmech.2021.113321","volume":"216","author":"Aaghaz S.","year":"2021","unstructured":"Aaghaz S.; Sharma K.; Jain R.; Kamal A.; \u03b2-Carbolines as potential anticancer agents. Eur J Med Chem  2021,216,113321","journal-title":"Eur J Med Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"626065","DOI":"10.3389\/fphar.2020.626065","volume":"11","author":"Miao J.","year":"2021","unstructured":"Miao J.; Meng C.; Wu H.; Shan W.; Wang H.; Ling C.; Zhang J.; Yang T.; Novel hybrid chc from \u03b2-carboline and n-hydroxyacrylamide overcomes drug-resistant hepatocellular carcinoma by promoting apoptosis, dna damage, and cell cycle arrest. Front Pharmacol  2021,11,626065","journal-title":"Front Pharmacol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.4155\/fmc-2018-0226","volume":"10","author":"Abdelsalam M.A.","year":"2018","unstructured":"Abdelsalam M.A.; AboulWafa, O.M.; Badawey, E.S.A.M.; El-Shoukrofy, M.S.; El-Miligy, M.M.; Gouda, N. Design and synthesis of some \u03b2-carboline derivatives as multi-target anticancer agents. Future Med Chem  2018,10(24),2791-2814","journal-title":"Future Med Chem"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/molecules26030663","volume":"26","author":"Szab\u00f3 T.","year":"2021","unstructured":"Szab\u00f3 T.; Volk B.; Milen M.; Recent advances in the synthesis of \u03b2-carboline alkaloids. Molecules  2021,26(3),663","journal-title":"Molecules"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.ejmcr.2022.100096","volume":"6","author":"Thatikayala M.","year":"2022","unstructured":"Thatikayala M.; Wadhwa P.; Kaur P.; Singh P.K.; Yadav A.; Kaushik M.; Sahu S.K.; Beta-carboline as a promising heterocyclic nucleus: Synthetic aspects, pharmacological potential and structure activity relationship. Eur J Med Chem Rep  2022,6,100096","journal-title":"Eur J Med Chem Rep"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ejmech.2018.08.027","volume":"157","author":"Dai J.","year":"2018","unstructured":"Dai J.; Dan W.; Schneider U.; Wang J.; \u03b2-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities. Eur J Med Chem  2018,157,622-656","journal-title":"Eur J Med Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/B978-1-4831-9671-8.50012-8","author":"Taylor W.I.","year":"1966","unstructured":"Taylor W.I.; The Complex Tetrahydro-B-Carboline Alkaloids. Indole Alkaloids  1966,52-72","journal-title":"Indole Alkaloids"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"115247","DOI":"10.1016\/j.ejmech.2023.115247","volume":"252","author":"Kushwaha P.","year":"2023","unstructured":"Kushwaha P.; Kumar V.; Saha B.; Current development of \u03b2-carboline derived potential antimalarial scaffolds. Eur J Med Chem  2023,252,115247","journal-title":"Eur J Med Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/0973-7847.120524","volume":"7","author":"Moloudizargari M.","year":"2013","unstructured":"Moloudizargari M.; Mikaili P.; Aghajanshakeri S.; Asghari M.; Shayegh J.; Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev  2013,7(14),199-212","journal-title":"Pharmacogn Rev"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"117350","DOI":"10.1016\/j.ejmech.2025.117350","volume":"287","author":"Rehman M.U.","year":"2025","unstructured":"Rehman M.U.; Zuo Y.; Tu N.; Guo J.; Liu Z.; Cao S.; Long S.; Diverse pharmacological activities of \u03b2-carbolines: Substitution patterns, SARs and mechanisms of action. Eur J Med Chem  2025,287,117350","journal-title":"Eur J Med Chem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1016\/j.bmc.2012.05.002","volume":"20","author":"Won T.H.","year":"2012","unstructured":"Won T.H.; Jeon J.; Lee S.H.; Rho B.J.; Oh K.B.; Shin J.; Beta-carboline alkaloids derived from the ascidian Synoicum sp. Bioorg Med Chem  2012,20(13),4082-4087","journal-title":"Bioorg Med Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"e2303327120","DOI":"10.1073\/pnas.2303327120","volume":"120","author":"Li X.L.","year":"2023","unstructured":"Li X.L.; Sun Y.; Yin Y.; Zhan S.; Wang C.; A bacterial-like Pictet\u2013Spenglerase drives the evolution of fungi to produce \u03b2-carboline glycosides together with separate genes. Proc Natl Acad Sci USA  2023,120(30),e2303327120","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/abbi.1996.9771","volume":"337","author":"Kim H.","year":"1997","unstructured":"Kim H.; Sablin S.O.; Ramsay R.R.; Inhibition of monoamine oxidase A by \u03b2-carboline derivatives. Arch Biochem Biophys  1997,337(1),137-142","journal-title":"Arch Biochem Biophys"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"21550","DOI":"10.1021\/acsomega.0c02165","volume":"5","author":"Roy S.","year":"2020","unstructured":"Roy S.; Mohammad T.; Gupta P.; Dahiya R.; Parveen S.; Luqman S.; Hasan G.M.; Hassan M.I.; Discovery of harmaline as a potent inhibitor of sphingosine kinase-1: A chemopreventive role in lung cancer. ACS Omega  2020,5(34),21550-21560","journal-title":"ACS Omega"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchromb.2003.10.044","volume":"802","author":"Pfau W.","year":"2004","unstructured":"Pfau W.; Skog K.; Exposure to \u03b2-carbolines norharman and harman. J Chromatogr B Analyt Technol Biomed Life Sci  2004,802(1),115-126","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=185","doi-asserted-by":"publisher","DOI":"10.5897\/AJPP11.876","volume":"6","author":"Jinous Asgarpanah","year":"2012","unstructured":"Jinous Asgarpanah ; Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr J Pharm Pharmacol  2012,6(22)","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/chemistry4040091","volume":"4","author":"Chourasiya R.","year":"2022","unstructured":"Chourasiya R.; Agrawal R.; Vaidya A.; promising anticancer activity of \u03b2-carboline derivatives: Design, Synthesis, and Pharmacological Evaluation. Chemistry  2022,4(4),1395-1406","journal-title":"Chemistry"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejmech.2014.09.048","volume":"87","author":"Otto R.","year":"2014","unstructured":"Otto R.; Penzis R.; Gaube F.; Winckler T.; Appenroth D.; Fleck C.; Tr\u00e4nkle C.; Lehmann J.; Enzensperger C.; Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison. Eur J Med Chem  2014,87,63-70","journal-title":"Eur J Med Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/jm00351a015","volume":"25","author":"Cain M.","year":"1982","unstructured":"Cain M.; Weber R.W.; Guzman F.; Cook J.M.; Barker S.A.; Rice K.C.; Crawley J.N.; Paul S.M.; Skolnick P.; beta.-Carbolines: Synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. J Med Chem  1982,25(9),1081-1091","journal-title":"J Med Chem"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"e202301263","DOI":"10.1002\/cbdv.202301263","volume":"21","author":"Tshikhudo P.P.","year":"2024","unstructured":"Tshikhudo P.P.; Mabhaudhi T.; Koorbanally N.A.; Mudau F.N.; Avenda\u00f1o Caceres E.O.; Popa D.; Calina D.; Sharifi-Rad J.; Anticancer potential of \u03b2\u2010carboline alkaloids: An updated mechanistic overview. Chem Biodivers  2024,21(2),e202301263","journal-title":"Chem Biodivers"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/jpet.102.047050","volume":"305","author":"Yu A.M.","year":"2003","unstructured":"Yu A.M.; Idle J.R.; Krausz K.W.; K\u00fcpfer A.; Gonzalez F.J.; Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic \u03b2-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther  2003,305(1),315-322","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/etm.2022.11132","volume":"23","author":"Chen Z.Y.","year":"2022","unstructured":"Chen Z.Y.; Li J.; Zhu S.D.; Li Z.D.; Yu J.L.; Wu J.; Zhang C.; Zeng L.H.; Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells. Exp Ther Med  2022,23(3),209","journal-title":"Exp Ther Med"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1080\/15384047.2015.1078021","volume":"16","author":"Zhang L.","year":"2015","unstructured":"Zhang L.; Zhang F.; Zhang W.; Chen L.; Gao N.; Men Y.; Xu X.; Jiang Y.; Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells. Cancer Biol Ther  2015,16(11),1585-1592","journal-title":"Cancer Biol Ther"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3746\/pnf.2023.28.4.436","volume":"28","author":"Kim G.D.","year":"2023","unstructured":"Kim G.D.; Harmine hydrochloride induces g2\/m cell cycle arrest and apoptosis in sk-hep1 hepatocellular carcinoma cells by regulating mitogen-activated protein kinases and the pi3k\/akt pathway. Prev Nutr Food Sci  2023,28(4),436-443","journal-title":"Prev Nutr Food Sci"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cbi.2016.08.024","volume":"258","author":"Sarkar S.","year":"2016","unstructured":"Sarkar S.; Bhattacharjee P.; Bhadra K.; DNA binding and apoptotic induction ability of harmalol in HepG2: Biophysical and biochemical approaches. Chem Biol Interact  2016,258,142-152","journal-title":"Chem Biol Interact"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3892\/etm.2019.7253","volume":"17","author":"Su H.","year":"2019","unstructured":"Su H.; Kang Q.; Wang H.; Yin H.; Duan L.; Liu Y.; Fan R.; Changes in expression of P53 and inflammatory factors in patients with ulcerative colitis. Exp Ther Med  2019,17(4),2451-2456","journal-title":"Exp Ther Med"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43094-020-00045-x","volume":"6","author":"Sarkar S.","year":"2020","unstructured":"Sarkar S.; Bhattacharjee P.; Ghosh T.; Bhadra K.; Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma. Future J Pharm Sci  2020,6(1),29","journal-title":"Future J Pharm Sci"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/ijo.2022.5335","volume":"60","author":"Zhang C.","year":"2022","unstructured":"Zhang C.; Wu L.W.; Li Z.D.; Zhang M.M.; Wu J.; Du F.H.; Zeng L.H.; Li Y.L.; DYRK1A suppression attenuates HIF 1\u03b1 accumulation and enhances the anti liver cancer effects of regorafenib and sorafenib under hypoxic conditions. Int J Oncol  2022,60(4),45","journal-title":"Int J Oncol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"e14521","DOI":"10.1111\/cbdd.14521","volume":"103","author":"Mishra S.","year":"2024","unstructured":"Mishra S.; Gupta A.; Jain S.; Vaidya A.; Anticancer mechanisms of \u03b2\u2010carbolines. Chem Biol Drug Des  2024,103(4),e14521","journal-title":"Chem Biol Drug Des"},{"key":"ref=199","doi-asserted-by":"publisher","DOI":"10.1007\/s11101-024-09978-0","author":"Timbilla A.A.","year":"2024","unstructured":"Timbilla A.A.; Vrabec R.; Havelek R.; Rezacova M.; Chlebek J.; Blunden G.; Cahlikova L.; The anticancer properties of harmine and its derivatives. Phytochem Rev  2024","journal-title":"Phytochem Rev"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"115776","DOI":"10.1016\/j.ejmech.2023.115776","volume":"260","author":"Chen X.","year":"2023","unstructured":"Chen X.; Wang J.; Zhao P.; Dang B.; Liang T.; Steimbach R.R.; Miller A.K.; Liu J.; Wang X.; Zhang T.; Luan X.; Hu J.; Gao J.; Tetrahydro-\u03b2-carboline derivatives as potent histone deacetylase 6 inhibitors with broad-spectrum antiproliferative activity. Eur J Med Chem  2023,260,115776","journal-title":"Eur J Med Chem"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"213746","DOI":"10.1016\/j.ccr.2020.213746","volume":"432","author":"Ayipo Y.O.","year":"2021","unstructured":"Ayipo Y.O.; Osunniran W.A.; Mordi M.N.; Metal complexes of \u03b2-carboline: Advances in anticancer therapeutics. Coord Chem Rev  2021,432,213746","journal-title":"Coord Chem Rev"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/s41388-021-01950-y","volume":"40","author":"Brahma M.K.","year":"2021","unstructured":"Brahma M.K.; Gilglioni E.H.; Zhou L.; Tr\u00e9po E.; Chen P.; Gurzov E.N.; Oxidative stress in obesity-associated hepatocellular carcinoma: Sources, signaling and therapeutic challenges. Oncogene  2021,40(33),5155-5167","journal-title":"Oncogene"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"111538","DOI":"10.1016\/j.intimp.2024.111538","volume":"129","author":"Ma Y.","year":"2024","unstructured":"Ma Y.; Li W.; Yao Q.; Liu Y.; Yu J.; Zang L.; Wang S.; Zhou L.; Wen S.; Luo Y.; Li W.; Niu X.; Harmine ameliorates CCl4-induced acute liver injury through suppression of autophagy and inflammation. Int Immunopharmacol  2024,129,111538","journal-title":"Int Immunopharmacol"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1293\/tox.18.99","volume":"18","author":"Sugiura S.","year":"2005","unstructured":"Sugiura S.; Asamoto M.; Hokaiwado N.; Hirose M.; Shirai T.; Harman and Norharman Suppressed but NaNO2 Enhanced the Development of Preneoplastic Liver Cell Foci in 2-Amino-3,8-Dimethylimidazo[4,5-f]Quinoxaline (MeIQx)-. Treated Rats J Toxicol Pathol  2005,18(2),99-104","journal-title":"Treated Rats J Toxicol Pathol"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.fct.2011.10.052","volume":"50","author":"El Gendy M.A.M.","year":"2012","unstructured":"El Gendy M.A.M.; Soshilov A.A.; Denison M.S.; El-Kadi A.O.S.; Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food Chem Toxicol  2012,50(2),353-362","journal-title":"Food Chem Toxicol"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"123","DOI":"10.13005\/bpj\/2106","volume":"14","author":"Beltagy D.M.","year":"2021","unstructured":"Beltagy D.M.; Abdelsalam K.G.; Mohamed T.M.; El-Keey M.M.; Role of harmaline as adiponectin modulator in defeating liver cirrhosis induced by thioacetamide in mice. Biomed Pharmacol J  2021,14(1),123-131","journal-title":"Biomed Pharmacol J"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1499-3872(11)60102-1","volume":"10","author":"Cao M.R.","year":"2011","unstructured":"Cao M.R.; Li Q.; Liu Z.L.; Liu H.H.; Wang W.; Liao X.L.; Pan Y.L.; Jiang J.W.; Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary Pancreat Dis Int  2011,10(6),599-604","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"103623","DOI":"10.1016\/j.jddst.2022.103623","volume":"75","author":"Hafiz I.","year":"2022","unstructured":"Hafiz I.; Li Z.; Wang Z.; He H.; Tang X.; Wang M.; Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response. J Drug Deliv Sci Technol  2022,75,103623","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"Nagaraju G.P.","year":"2022","unstructured":"Nagaraju G.P.; Dariya B.; Kasa P.; Peela S.; El-Rayes B.F.; Epigenetics in hepatocellular carcinoma. Semin Cancer Biol  2022,86(Pt 3),622-632","journal-title":"Semin Cancer Biol"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1039\/C6MD00681G","volume":"8","author":"Liu J.","year":"2017","unstructured":"Liu J.; Wang T.; Wang X.; Luo L.; Guo J.; Peng Y.; Xu Q.; Miao J.; Zhang Y.; Ling Y.; Development of novel \u03b2-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities. MedChemComm  2017,8(6),1213-1219","journal-title":"MedChemComm"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1021\/acschembio.3c00065","volume":"18","author":"Cho C.C.","year":"2023","unstructured":"Cho C.C.; Lin C.J.; Huang H.H.; Yang W.Z.; Fei C.Y.; Lin H.Y.; Lee M.S.; Yuan H.S.; Mechanistic insights into harmine-mediated inhibition of human dna methyltransferases and prostate cancer cell growth. ACS Chem Biol  2023,18(6),1335-1350","journal-title":"ACS Chem Biol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12672-025-01893-w","volume":"16","author":"Joshi H.","year":"2025","unstructured":"Joshi H.; Bhushan S.; Dimri T.; Sharma D.; Sak K.; Chauhan A.; Chauhan R.; Haque S.; Ahmad F.; Kumar M.; Tuli H.S.; Kaur D.; Anti-tumor potential of Harmine and its derivatives: Recent trends and advancements. Discov Oncol  2025,16(1),189","journal-title":"Discov Oncol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/life13112150","volume":"13","author":"Chou A.H.","year":"2023","unstructured":"Chou A.H.; Lee H.C.; Liao C.C.; Yu H.P.; Liu F.C.; ERK\/NF-kB\/COX-2 signaling pathway plays a key role in curcumin protection against acetaminophen-induced liver injury. Life  2023,13(11),2150","journal-title":"Life"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.7150\/jca.76663","volume":"13","author":"Xie D.P.","year":"2022","unstructured":"Xie D.P.; Gong Y.X.; Lee J.; Jeong E.M.; Ren C.X.; Guo X.Y.; Han Y.H.; Cui Y.D.; Lee S.J.; Kwon T.; Sun H.N.; Peroxiredoxin 5 protects HepG2 cells from ethyl \u03b2-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathways. J Cancer  2022,13(11),3258-3267","journal-title":"J Cancer"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ptr.5497","volume":"30","author":"Zhang P.","year":"2016","unstructured":"Zhang P.; Huang C.; Wang W.; Zhang X.; Chen J.; Wang J.; Lin C.; Jiang J.; Harmine hydrochloride triggers g2 phase arrest and apoptosis in mgc-803 cells and smmc-7721 cells by upregulating p21, activating caspase-8\/bid, and downregulating erk\/bad pathway. Phytother Res  2016,30(1),31-40","journal-title":"Phytother Res"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.toxlet.2011.09.030","volume":"208","author":"El Gendy M.A.M.","year":"2012","unstructured":"El Gendy M.A.M.; Soshilov A.A.; Denison M.S.; El-Kadi A.O.S.; Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol. Toxicol Lett  2012,208(1),51-61","journal-title":"Toxicol Lett"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1080\/03639045.2019.1620267","volume":"45","author":"Prasad Kushwaha J.","year":"2019","unstructured":"Prasad Kushwaha J.; Baidya D.; Patil S.; Harmine-loaded galactosylated pluronic F68-gelucire 44\/14 mixed micelles for liver targeting. Drug Dev Ind Pharm  2019,45(8),1361-1368","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1517\/17425247.2014.893292","volume":"11","author":"Bei Y.Y.","year":"2014","unstructured":"Bei Y.Y.; Yuan Z.Q.; Zhang L.; Zhou X.F.; Chen W.L.; Xia P.; Liu Y.; You B.G.; Hu X.J.; Zhu Q.L.; Zhang C.G.; Zhang X.N.; Jin Y.; Novel self-assembled micelles based on palmitoyl-trimethyl-chitosan for efficient delivery of harmine to liver cancer. Expert Opin Drug Deliv  2014,11(6),843-854","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"8988","DOI":"10.18632\/oncotarget.3276","volume":"6","author":"Li S.","year":"2015","unstructured":"Li S.; Wang A.; Gu F.; Wang Z.; Tian C.; Qian Z.; Tang L.; Gu Y.; Novel harmine derivatives for tumor targeted therapy. Oncotarget  2015,6(11),8988-9001","journal-title":"Oncotarget"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/258095","volume":"2013","author":"El Gendy M.A.M.","year":"2013","unstructured":"El Gendy M.A.M.; El-Kadi A.O.S.; Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL\/6 mice. BioMed Res Int  2013,2013,1-9","journal-title":"BioMed Res Int"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"e31678","DOI":"10.1016\/j.heliyon.2024.e31678","volume":"10","author":"Mohammadi F.","year":"2024","unstructured":"Mohammadi F.; Ghaleh navi, N.; Karimi, E.; Homayouni-Tabrizi, M.; Oskoueian, E. Nanoparticle-based delivery of harmine: A comprehensive study on synthesis, characterization, anticancer activity, angiogenesis and toxicity evaluation. Heliyon  2024,10(11),e31678","journal-title":"Heliyon"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fct.2009.12.019","volume":"48","author":"Herraiz T.","year":"2010","unstructured":"Herraiz T.; Gonz\u00e1lez D.; Anc\u00edn-Azpilicueta C.; Ar\u00e1n V.J.; Guill\u00e9n H.; \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol  2010,48(3),839-845","journal-title":"Food Chem Toxicol"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"e34183","DOI":"10.1016\/j.heliyon.2024.e34183","volume":"10","author":"Sarkar P.","year":"2024","unstructured":"Sarkar P.; Gopi P.; Pandya P.; Paria S.; Hossain M.; Siddiqui M.H.; Alamri S.; Bhadra K.; Insights on the comparative affinity of ribonucleic acids with plant-based beta carboline alkaloid, harmine: Spectroscopic, calorimetric and computational evaluation. Heliyon  2024,10(14),e34183","journal-title":"Heliyon"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1089\/dna.2008.0779","volume":"27","author":"Bhadra K.","year":"2008","unstructured":"Bhadra K.; Maiti M.; Kumar G.S.; DNA-binding cytotoxic alkaloids: Comparative study of the energetics of binding of berberine, palmatine, and coralyne. DNA Cell Biol  2008,27(12),675-685","journal-title":"DNA Cell Biol"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.bbagen.2007.03.001","volume":"1770","author":"Bhadra K.","year":"2007","unstructured":"Bhadra K.; Maiti M.; Kumar G.S.; Molecular recognition of DNA by small molecules: AT base pair specific intercalative binding of cytotoxic plant alkaloid palmatine. Biochim Biophys Acta, Gen Subj  2007,1770(7),1071-1080","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10238-024-01463-4","volume":"24","author":"Zhang L.","year":"2024","unstructured":"Zhang L.; Lou W.; Wang J.; Advances in nucleic acid therapeutics: Structures, delivery systems, and future perspectives in cancer treatment. Clin Exp Med  2024,24(1),200","journal-title":"Clin Exp Med"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.3390\/molecules25245963","volume":"25","author":"Hawner M.","year":"2020","unstructured":"Hawner M.; Ducho C.; Cellular targeting of oligonucleotides by conjugation with small molecules. Molecules  2020,25(24),5963","journal-title":"Molecules"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","volume":"22","author":"Dhyani P.","year":"2022","unstructured":"Dhyani P.; Quispe C.; Sharma E.; Bahukhandi A.; Sati P.; Attri D.C.; Szopa A.; Sharifi-Rad J.; Docea A.O.; Mardare I.; Calina D.; Cho W.C.; Anticancer potential of alkaloids: A key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int  2022,22(1),206","journal-title":"Cancer Cell Int"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3390\/biology10121225","volume":"10","author":"Jaro\u0161ov\u00e1 P.","year":"2021","unstructured":"Jaro\u0161ov\u00e1 P.; Hannig P.; Kolkov\u00e1 K.; Mazzini S.; T\u00e1borsk\u00e1 E.; Gargallo R.; Borgonovo G.; Artali R.; T\u00e1borsk\u00fd P.; Alkaloid escholidine and its interaction with DNA structures. Biology  2021,10(12),1225","journal-title":"Biology"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0141-8130(81)90062-3","volume":"3","author":"Duportail G.","year":"1981","unstructured":"Duportail G.; Linear and circular dichroism of harmine and harmaline interacting with DNA. Int J Biol Macromol  1981,3(3),188-192","journal-title":"Int J Biol Macromol"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jphotobiol.2013.11.021","volume":"130","author":"Sarkar S.","year":"2014","unstructured":"Sarkar S.; Bhadra K.; Binding of alkaloid harmalol to DNA: Photophysical and calorimetric approach. J Photochem Photobiol B  2014,130,272-280","journal-title":"J Photochem Photobiol B"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1093\/nar\/4.11.3679","volume":"4","author":"Hayashi K.","year":"1977","unstructured":"Hayashi K.; Nagao M.; Sugimura T.; Interactions of norharman and harman with DNA. Nucleic Acids Res  1977,4(11),3679-3686","journal-title":"Nucleic Acids Res"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0006-291X(77)91129-9","volume":"79","author":"Levitt R.C.","year":"1977","unstructured":"Levitt R.C.; Legraverend C.; Nebert D.W.; Pelkonen O.; Effects of harman and norharman on the mutagenicity and binding to DNA of benzo[a]pyrene metabolites in vitro and on aryl hydrocarbon hydroxylase induction in cell culture. Biochem Biophys Res Commun  1977,79(4),1167-1175","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/molecules22111831","volume":"22","author":"Pagano B.","year":"2017","unstructured":"Pagano B.; Caterino M.; Filosa R.; Giancola C.; Binding of harmine derivatives to DNA: A spectroscopic investigation. Molecules  2017,22(11),1831","journal-title":"Molecules"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.bbrc.2005.10.121","volume":"338","author":"Cao R.","year":"2005","unstructured":"Cao R.; Peng W.; Chen H.; Ma Y.; Liu X.; Hou X.; Guan H.; Xu A.; DNA binding properties of 9-substituted harmine derivatives. Biochem Biophys Res Commun  2005,338(3),1557-1563","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/dna.2010.1087","volume":"29","author":"Nafisi S.","year":"2010","unstructured":"Nafisi S.; Malekabady Z.M.; Khalilzadeh M.A.; Interaction of \u03b2-Carboline Alkaloids with RNA. DNA Cell Biol  2010,29(12),753-761","journal-title":"DNA Cell Biol"},{"key":"ref=237","doi-asserted-by":"publisher","DOI":"10.5935\/0103-5053.20160035","author":"Silva M.M.","year":"2016","unstructured":"Silva M.M.; Savariz F.C.; Silva-J\u00fanior E.F.; Aquino T.M.; Sarragiotto M.H.; Santos J.C.C.; Figueiredo I.M.; interaction Of B-Carbolines With DNA: Spectroscopic Studies, Correlation With Biological Activity And Molecular Docking. J Braz Chem Soc  2016","journal-title":"J Braz Chem Soc"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cbi.2016.08.025","volume":"260","author":"Sharma S.","year":"2016","unstructured":"Sharma S.; Yadav M.; Gupta S.P.; Pandav K.; Kumar S.; Spectroscopic and structural studies on the interaction of an anticancer \u03b2\u2013carboline alkaloid, harmine with GC and AT specific DNA oligonucleotides. Chem Biol Interact  2016,260,256-262","journal-title":"Chem Biol Interact"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1080\/07391102.2021.1874533","volume":"40","author":"Sarkar S.","year":"2022","unstructured":"Sarkar S.; Tribedi P.; Bhadra K.; Structure-activity insights of harmine targeting DNA, ROS inducing cytotoxicity with PARP mediated apoptosis against cervical cancer, anti-biofilm formation and in vivo therapeutic study. J Biomol Struct Dyn  2022,40(13),5880-5902","journal-title":"J Biomol Struct Dyn"},{"key":"ref=240","first-page":"125","volume":"10","author":"Vaishnav N.","year":"2020","unstructured":"Vaishnav N.; Khare N.; Katariya P.K.; Jha A.K.; To study the effect of harmine against DNMT1 for the treatment of cervical cancer through molecular docking studies. IJPBS  2020,10(3),125-132","journal-title":"IJPBS"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tca.2003.11.025","volume":"416","author":"Du W.","year":"2004","unstructured":"Du W.; Wang B.; Li Z.; Interaction of harmine with oligonucleotide d(GTGCAC)2. Thermochim Acta  2004,416(1-2),59-63","journal-title":"Thermochim Acta"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jcis.2018.12.011","volume":"538","author":"Paul B.K.","year":"2019","unstructured":"Paul B.K.; Ghosh N.; Mukherjee S.; Binding of norharmane with RNA reveals two thermodynamically different binding modes with opposing heat capacity changes. J Colloid Interface Sci  2019,538,587-596","journal-title":"J Colloid Interface Sci"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"e108022","DOI":"10.1371\/journal.pone.0108022","volume":"9","author":"Sarkar S.","year":"2014","unstructured":"Sarkar S.; Pandya P.; Bhadra K.; Sequence specific binding of beta carboline alkaloid harmalol with deoxyribonucleotides: Binding heterogeneity, conformational, thermodynamic and cytotoxic aspects. PLoS One  2014,9(9),e108022","journal-title":"PLoS One"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2015.1126694","volume":"34","author":"Bhattacharjee P.","year":"2016","unstructured":"Bhattacharjee P.; Sarkar S.; Pandya P.; Bhadra K.; Targeting different RNA motifs by beta carboline alkaloid, harmalol: A comparative photophysical, calorimetric, and molecular docking approach. J Biomol Struct Dyn  2016,34(12),1-19","journal-title":"J Biomol Struct Dyn"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0960-894X(00)00679-X","volume":"11","author":"Xiao S.","year":"2001","unstructured":"Xiao S.; Lin W.; Wang C.; Yang M.; Synthesis and biological evaluation of DNA targeting flexible side-chain substituted \u03b2-carboline derivatives. Bioorg Med Chem Lett  2001,11(4),437-441","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fphar.2017.00541","volume":"8","author":"Li S.","year":"2017","unstructured":"Li S.; Zhang Y.; Deng G.; Wang Y.; Qi S.; Cheng X.; Ma Y.; Xie Y.; Wang C.; Exposure characteristics of the analogous \u03b2-carboline alkaloids harmaline and harmine based on the efflux transporter of multidrug resistance protein 2. Front Pharmacol  2017,8,541","journal-title":"Front Pharmacol"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.etp.2007.12.003","volume":"60","author":"Jim\u00e9nez J.","year":"2008","unstructured":"Jim\u00e9nez J.; River\u00f3n-Negrete L.; Abdullaev F.; Espinosa-Aguirre J.; Rodr\u00edguez-Arnaiz R.; Cytotoxicity of the \u03b2-carboline alkaloids harmine and harmaline in human cell assays in vitro. Exp Toxicol Pathol  2008,60(4-5),381-389","journal-title":"Exp Toxicol Pathol"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jep.2017.03.049","volume":"203","author":"Li S.","year":"2017","unstructured":"Li S.; Cheng X.; Wang C.; A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J Ethnopharmacol  2017,203,127-162","journal-title":"J Ethnopharmacol"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.jddst.2020.101515","volume":"56","author":"Salehi H.","year":"2020","unstructured":"Salehi H.; Karimi M.; Rezaie N.; Raofie F.; Extraction of \u03b2-Carboline alkaloids and preparation of extract nanoparticles from Peganum harmala L. capsules using supercritical fluid technique. J Drug Deliv Sci Technol  2020,56,101515","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.ijpharm.2021.120268","volume":"596","author":"Arslan F.B.","year":"2021","unstructured":"Arslan F.B.; Ozturk K.; Calis S.; Antibody-mediated drug delivery. Int J Pharm  2021,596,120268","journal-title":"Int J Pharm"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"109038","DOI":"10.1016\/j.cbpc.2021.109038","volume":"245","author":"Sun Q.","year":"2021","unstructured":"Sun Q.; Liu C.; Jiang K.; Fang Y.; Kong C.; Fu J.; Liu Y.; A preliminary study on the neurotoxic mechanism of harmine in Caenorhabditis elegans. Comp Biochem Physiol C Toxicol Pharmacol  2021,245,109038","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"Elumalai K.","year":"2024","unstructured":"Elumalai K.; Srinivasan S.; Shanmugam A.; Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed Tech  2024,5,109-122","journal-title":"Biomed Tech"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"735446","DOI":"10.3389\/fphar.2021.735446","volume":"12","author":"Liu G.","year":"2021","unstructured":"Liu G.; Yang L.; Chen G.; Xu F.; Yang F.; Yu H.; Li L.; Dong X.; Han J.; Cao C.; Qi J.; Su J.; Xu X.; Li X.; Li B.; A Review on Drug Delivery System for Tumor Therapy. Front Pharmacol  2021,12,735446","journal-title":"Front Pharmacol"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.urolonc.2009.03.017","volume":"28","author":"Lotan Y.","year":"2010","unstructured":"Lotan Y.; Role of biomarkers to predict outcomes and response to therapy. Urol Oncol  2010,28(1),97-101","journal-title":"Urol Oncol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575415295250922074231","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/245913\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575415295250922074231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:37:42Z","timestamp":1778733462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/245913\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":254,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575415295250922074231","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}